je.st
news
ImmunoGen Announces Executive Change
2013-08-28 10:02:56| Biotech - Topix.net
ImmunoGen, Inc. , a biotechnology company that develops novel anticancer therapeutics using its proprietary antibody-drug conjugate technology, today announced that Gregory D. Perry, Executive Vice President and Chief Financial Officer, has provided notice of his intention to resign from the Company to pursue other interests.
Tags: change
executive
announces
immunogen
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|